Non-invasive biochemical analysis

• US 7,330,746 B2
• Filed: 06/07/2005
• Issued: 02/12/2008
• Est. Priority Date: 06/07/2005
• Status: Active Grant

• Current Assignee: Chemimage Corporation
• Original Assignee: Chemimage Corporation
• Inventors: Treado, Patrick J., Cohen, Jeffrey K., Demuth, Joseph E., Maier, John S.
• Primary Examiner(s): Winakur; Eric
• Assistant Examiner(s): Berhanu; Etsub D
• Application Number:
  US11/146,458
• Publication Number:
  US 20060276697A1
• Time in Patent Office: 980 Days
• Field of Search: 600/310, 600/322, 600/323, 600/475, 600/478
• US Class Current: 600/322
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/14546 for measuring analytes not otherwise provided for, e.g. ions, cytochromes
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters
• CPC Class Codes: A61B 5/415 the glands, e.g. tonsils, adenoids or thymus
• CPC Class Codes: A61B 5/418 lymph vessels, ducts or nodes

Abstract

The invention relates to methods and devices for assessing one or more blood components in an animal. The present invention permits non-invasive assessment of blood components in a body structure containing blood and other tissue types by assessing multiple regions of a tissue surface for an optical characteristic of blood and separately assessing one or more optical (e.g., Raman or NIR) characteristics of the blood component for one or more regions that exhibit the optical characteristic of blood.

Claims

1. A method of assessing a component of the blood of an animal, the method comprising performing the following steps non-invasively:

irradiating a plurality of regions on a vascularized surface of the animal to generate radiation therefrom;

evaluating a first optical property of each of said plurality of irradiated regions to identify at least one of said plurality of regions on the surface exhibiting a first optical characteristic of the blood, said first optical characteristic associated with said first optical property;

selectively controlling irradiation of one or more of said plurality of regions that fail to exhibit said first optical characteristic of the blood;

obtaining a second optical property from at least one identified region in said plurality of regions exhibiting said first optical characteristic, wherein said first and said second optical properties are generated by different spectroscopic modes, wherein the second optical property is generated by transmitting radiation, generated from said at least one identified region, through a filter, thereby obtaining filtered photons;

assessing said component in said at least one identified region by evaluating said filtered photons for a second optical characteristic associated with said component; and

reporting an identity of said component based on said assessment thereof.

2. The method of claim 1, wherein the second optical characteristic of the component is assessed for at least two identified regions.

3. The method of claim 1, wherein Raman-shifted radiation scattered from multiple identified regions is assessed substantially simultaneously.

4. The method of claim 1, wherein the surface is the apical surface of a non-dermal epithelium.

5. The method of claim 1, wherein the surface is the apical surface of a non-keratinized epithelium.

6. The method of claim 1, wherein the vascularized surface is an epithelium that is selected from the group consisting of the floor of the mouth, the soft palate, the lingual surface of the tongue, inner cheek surfaces, esophagus lining, stomach wall lining, intestinal and colonic linings, olfactory epithelium, pharyngeal epithelium, bronchial epithelium, alveolar epithelium, urethral epithelium, vaginal epithelium, and vulval epithelium.

7. The method of claim 1, wherein the component is selected from the group consisting of glucose, dissolved oxygen, dissolved carbon dioxide, urea, lactic acid, creatine, bicarbonate, an electrolyte, protein, cholesterol, triglycerides, lipids other than triglycerides, and hemoglobin.

8. The method of claim 1, wherein the component is glucose.

9. The method of claim 1, wherein the first optical characteristic is an optical characteristic of hemoglobin.

10. The method of claim 1, wherein the first optical characteristic is an optical characteristic other than Raman shift of light scattered from the region.

11. The method of claim 1, wherein Raman-shifted radiation scattered by each region that exhibits the first optical characteristic is transmitted to a detector using at least one discrete optical fiber for each such region.

12. The method of claim 1, wherein Raman-shifted scattered radiation scattered by each region that exhibits the first optical characteristic is transmitted to a detector using multiple discrete optical fibers for each such region.

13. The method of claim 1, wherein the regions are irradiated with substantially monochromatic light.

14. The method of claim 13, wherein the light has a wavelength not greater than about 600 nanometers.

15. The method of claim 13, wherein the light has a wavelength not greater than about 800 nanometers.

16. The method of claim 1, wherein the regions are irradiated with light from a laser.

17. The method of claim 1, wherein the animal is a human.

18. The method of claim 1, wherein said selectively controlling includes terminating irradiation of one or more of said plurality of regions that fail to exhibit said first optical characteristic prior to obtaining said second optical property.

19. The method of claim 1, wherein said selectively controlling includes redirecting irradiation associated with one or more of said plurality of regions that fail to exhibit said first optical characteristic to said at least one identified region exhibiting said first optical characteristic prior to obtaining said second optical property.

20. The method of claim 1, wherein said assessing said component includes performing spectral unmixing during evaluation of said filtered photons for said second optical characteristic.

21. A device for non-invasively assessing a component of the blood of an animal, the device comprising:

a first detector for detecting a first optical characteristic of the blood at each of multiple irradiated regions on a vascularized surface of the animal, the multiple regions having a pre-determined geometric relationship,

a controller operably linked to the first detector to identify at least one of the multiple regions exhibiting said first optical characteristic of the blood, said controller being configured to selectively control irradiation of one or more of said multiple regions that fail to exhibit said first optical characteristic of the blood;

a Raman detector for detecting Raman-shifted radiation; and

a filter interposed between said Raman detector and said multiple regions to filter Raman-shifted radiation received from said multiple irradiated regions and transmit filtered radiation to said Raman detector;

wherein said controller is operably linked to said Raman detector for restricting detection of Raman-shifted scattered radiation to only those regions exhibiting said first optical characteristic of blood and for evaluating said filtered radiation for a second optical characteristic associated with said component, wherein said controller is configured to report an identity of said component based on said evaluation.

22. A device for non-invasively assessing a component of the blood of an animal, the device comprising:

a radiation source for irradiating multiple regions on a vascularized surface of the animal, light being conveyed from the radiation source to each of the regions by at least one discrete optical illumination fiber for each region, the multiple regions having a pre-determined geometric relationship;

a non-Raman detector for detecting a first optical characteristic of the blood at each of multiple irradiated regions on a vascularized surface of the animal, the multiple regions having a pre-determined geometric relationship;

a controller operably linked to the non-Raman detector to identify at least one of the multiple regions exhibiting said first optical characteristic of the blood, said controller being configured to selectively control irradiation of one or more of said multiple regions that fail to exhibit said first optical characteristic of the blood; and

a Raman detector operably linked to said controller and controlled thereby for restricting detection of Raman-shifted radiation to only those regions that exhibit said first optical characteristic of the blood, there being optically coupled with the Raman detector and interposed between the Raman detector and the regions an optical filter and at least one discrete optical detection fiber for each region;

wherein said controller is configured to control said Raman detector to receive radiation from said optical filter, and wherein said controller is further configured to evaluate output of said Raman detector for a second optical characteristic associated with said component so as to report an identity of said component based on said evaluation.